Guobang Pharma Ltd. (SHA:605507)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Pharmaceutical	3.82B
Pharmaceutical Growth	9.65%
Animal Health Products	2.02B
Animal Health Products Growth	9.94%
Other Business	23.85M
Other Business Growth	6.70%
Other	28.26M
Other Growth	296.33%
Other	28.26M
Other Growth	296.33%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
China	3.20B
China Growth	11.74%
Overseas	2.66B
Overseas Growth	8.27%